Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Long-Term Debt Repayments (2018 - 2019)

Historic Long-Term Debt Repayments for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q3 2019 value amounting to $6.5 million.

  • X4 Pharmaceuticals' Long-Term Debt Repayments rose 119080.0% to $6.5 million in Q3 2019 from the same period last year, while for Dec 2020 it was $6.5 million, marking a year-over-year decrease of 4546.22%. This contributed to the annual value of $2.1 million for FY2023, which is 15962.26% up from last year.
  • Latest data reveals that X4 Pharmaceuticals reported Long-Term Debt Repayments of $6.5 million as of Q3 2019, which was up 119080.0% from $4.9 million recorded in Q4 2018.
  • Over the past 5 years, X4 Pharmaceuticals' Long-Term Debt Repayments peaked at $6.5 million during Q3 2019, and registered a low of $500000.0 during Q1 2018.